Atlas Trials

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

Clinical trial NCT06122285 · RECRUITING

Trial details

NCT number
NCT06122285
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Status
RECRUITING
Study type
OBSERVATIONAL
Hepatitis D
Start date
2023-05-01
Primary completion
2023-11-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.